
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England
Erik Volz, Swapnil Mishra, Meera Chand, et al.
Nature (2021) Vol. 593, Iss. 7858, pp. 266-269
Open Access | Times Cited: 1189
Erik Volz, Swapnil Mishra, Meera Chand, et al.
Nature (2021) Vol. 593, Iss. 7858, pp. 266-269
Open Access | Times Cited: 1189
Showing 1-25 of 1189 citing articles:
Features, Evaluation and Treatment Coronavirus (COVID-19)
Marco Cascella, Michael Rajnik, Arturo Cuomo, et al.
StatPearls (2020)
Closed Access | Times Cited: 2796
Marco Cascella, Michael Rajnik, Arturo Cuomo, et al.
StatPearls (2020)
Closed Access | Times Cited: 2796
Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa
Raquel Viana, Sikhulile Moyo, Daniel G. Amoako, et al.
Nature (2022) Vol. 603, Iss. 7902, pp. 679-686
Open Access | Times Cited: 1587
Raquel Viana, Sikhulile Moyo, Daniel G. Amoako, et al.
Nature (2022) Vol. 603, Iss. 7902, pp. 679-686
Open Access | Times Cited: 1587
Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil
Nuno R. Faria, Thomas A. Mellan, Charles Whittaker, et al.
Science (2021) Vol. 372, Iss. 6544, pp. 815-821
Open Access | Times Cited: 1435
Nuno R. Faria, Thomas A. Mellan, Charles Whittaker, et al.
Science (2021) Vol. 372, Iss. 6544, pp. 815-821
Open Access | Times Cited: 1435
Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic
Salim S. Abdool Karim, Quarraisha Abdool Karim
The Lancet (2021) Vol. 398, Iss. 10317, pp. 2126-2128
Open Access | Times Cited: 1289
Salim S. Abdool Karim, Quarraisha Abdool Karim
The Lancet (2021) Vol. 398, Iss. 10317, pp. 2126-2128
Open Access | Times Cited: 1289
SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion
Petra Mlčochová, Steven A. Kemp, Mahesh Shanker Dhar, et al.
Nature (2021) Vol. 599, Iss. 7883, pp. 114-119
Open Access | Times Cited: 1279
Petra Mlčochová, Steven A. Kemp, Mahesh Shanker Dhar, et al.
Nature (2021) Vol. 599, Iss. 7883, pp. 114-119
Open Access | Times Cited: 1279
The biological and clinical significance of emerging SARS-CoV-2 variants
Kaiming Tao, Philip L. Tzou, Janin Nouhin, et al.
Nature Reviews Genetics (2021) Vol. 22, Iss. 12, pp. 757-773
Open Access | Times Cited: 976
Kaiming Tao, Philip L. Tzou, Janin Nouhin, et al.
Nature Reviews Genetics (2021) Vol. 22, Iss. 12, pp. 757-773
Open Access | Times Cited: 976
Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review
Thibault Fiolet, Yousra Kherabi, Conor-James MacDonald, et al.
Clinical Microbiology and Infection (2021) Vol. 28, Iss. 2, pp. 202-221
Open Access | Times Cited: 820
Thibault Fiolet, Yousra Kherabi, Conor-James MacDonald, et al.
Clinical Microbiology and Infection (2021) Vol. 28, Iss. 2, pp. 202-221
Open Access | Times Cited: 820
Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2
Dami A. Collier, Isabella A. T. M. Ferreira, Prasanti Kotagiri, et al.
Nature (2021) Vol. 596, Iss. 7872, pp. 417-422
Open Access | Times Cited: 668
Dami A. Collier, Isabella A. T. M. Ferreira, Prasanti Kotagiri, et al.
Nature (2021) Vol. 596, Iss. 7872, pp. 417-422
Open Access | Times Cited: 668
Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individuals
Alison Tarke, John Sidney, Nils Methot, et al.
Cell Reports Medicine (2021) Vol. 2, Iss. 7, pp. 100355-100355
Open Access | Times Cited: 618
Alison Tarke, John Sidney, Nils Methot, et al.
Cell Reports Medicine (2021) Vol. 2, Iss. 7, pp. 100355-100355
Open Access | Times Cited: 618
Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study
Katherine A. Twohig, Tommy Nyberg, Asad Zaidi, et al.
The Lancet Infectious Diseases (2021) Vol. 22, Iss. 1, pp. 35-42
Open Access | Times Cited: 523
Katherine A. Twohig, Tommy Nyberg, Asad Zaidi, et al.
The Lancet Infectious Diseases (2021) Vol. 22, Iss. 1, pp. 35-42
Open Access | Times Cited: 523
The N501Y spike substitution enhances SARS-CoV-2 infection and transmission
Yang Liu, Jianying Liu, Kenneth S. Plante, et al.
Nature (2021) Vol. 602, Iss. 7896, pp. 294-299
Open Access | Times Cited: 483
Yang Liu, Jianying Liu, Kenneth S. Plante, et al.
Nature (2021) Vol. 602, Iss. 7896, pp. 294-299
Open Access | Times Cited: 483
Viral infection and transmission in a large, well-traced outbreak caused by the SARS-CoV-2 Delta variant
Baisheng Li, Aiping Deng, Kuibiao Li, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 443
Baisheng Li, Aiping Deng, Kuibiao Li, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 443
Spread of a SARS-CoV-2 variant through Europe in the summer of 2020
Emma B. Hodcroft, Moira Zuber, Sarah Nadeau, et al.
Nature (2021) Vol. 595, Iss. 7869, pp. 707-712
Open Access | Times Cited: 416
Emma B. Hodcroft, Moira Zuber, Sarah Nadeau, et al.
Nature (2021) Vol. 595, Iss. 7869, pp. 707-712
Open Access | Times Cited: 416
Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7
Bo Meng, Steven A. Kemp, Guido Papa, et al.
Cell Reports (2021) Vol. 35, Iss. 13, pp. 109292-109292
Open Access | Times Cited: 412
Bo Meng, Steven A. Kemp, Guido Papa, et al.
Cell Reports (2021) Vol. 35, Iss. 13, pp. 109292-109292
Open Access | Times Cited: 412
Clinical and Virological Features of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern: A Retrospective Cohort Study Comparing B.1.1.7 (Alpha), B.1.351 (Beta), and B.1.617.2 (Delta)
Sean Wei Xiang Ong, Calvin J. Chiew, Li Wei Ang, et al.
Clinical Infectious Diseases (2021) Vol. 75, Iss. 1, pp. e1128-e1136
Open Access | Times Cited: 389
Sean Wei Xiang Ong, Calvin J. Chiew, Li Wei Ang, et al.
Clinical Infectious Diseases (2021) Vol. 75, Iss. 1, pp. e1128-e1136
Open Access | Times Cited: 389
SARS-CoV-2 Variants and Vaccines
Philip R. Krause, Thomas R. Fleming, Ira M. Longini, et al.
New England Journal of Medicine (2021) Vol. 385, Iss. 2, pp. 179-186
Open Access | Times Cited: 381
Philip R. Krause, Thomas R. Fleming, Ira M. Longini, et al.
New England Journal of Medicine (2021) Vol. 385, Iss. 2, pp. 179-186
Open Access | Times Cited: 381
Novel SARS-CoV-2 variants: the pandemics within the pandemic
Erik Boehm, Ilona Kronig, Richard A. Neher, et al.
Clinical Microbiology and Infection (2021) Vol. 27, Iss. 8, pp. 1109-1117
Open Access | Times Cited: 358
Erik Boehm, Ilona Kronig, Richard A. Neher, et al.
Clinical Microbiology and Infection (2021) Vol. 27, Iss. 8, pp. 1109-1117
Open Access | Times Cited: 358
The emergence, genomic diversity and global spread of SARS-CoV-2
Juan Li, Shengjie Lai, George F. Gao, et al.
Nature (2021) Vol. 600, Iss. 7889, pp. 408-418
Open Access | Times Cited: 344
Juan Li, Shengjie Lai, George F. Gao, et al.
Nature (2021) Vol. 600, Iss. 7889, pp. 408-418
Open Access | Times Cited: 344
Evolution of enhanced innate immune evasion by SARS-CoV-2
Lucy Thorne, Mehdi Bouhaddou, Ann‐Kathrin Reuschl, et al.
Nature (2021) Vol. 602, Iss. 7897, pp. 487-495
Open Access | Times Cited: 330
Lucy Thorne, Mehdi Bouhaddou, Ann‐Kathrin Reuschl, et al.
Nature (2021) Vol. 602, Iss. 7897, pp. 487-495
Open Access | Times Cited: 330
The origins and potential future of SARS-CoV-2 variants of concern in the evolving COVID-19 pandemic
Sarah P. Otto, Troy Day, Julien Arino, et al.
Current Biology (2021) Vol. 31, Iss. 14, pp. R918-R929
Open Access | Times Cited: 323
Sarah P. Otto, Troy Day, Julien Arino, et al.
Current Biology (2021) Vol. 31, Iss. 14, pp. R918-R929
Open Access | Times Cited: 323
Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study
Mark S. Graham, Carole H. Sudre, Anna May, et al.
The Lancet Public Health (2021) Vol. 6, Iss. 5, pp. e335-e345
Open Access | Times Cited: 309
Mark S. Graham, Carole H. Sudre, Anna May, et al.
The Lancet Public Health (2021) Vol. 6, Iss. 5, pp. e335-e345
Open Access | Times Cited: 309
Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variant
Jun Zhang, Tianshu Xiao, Yongfei Cai, et al.
Science (2021) Vol. 374, Iss. 6573, pp. 1353-1360
Open Access | Times Cited: 289
Jun Zhang, Tianshu Xiao, Yongfei Cai, et al.
Science (2021) Vol. 374, Iss. 6573, pp. 1353-1360
Open Access | Times Cited: 289
SARS-CoV-2 Variants, Vaccines, and Host Immunity
Priyal Mistry, Fatima Barmania, Juanita Mellet, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 275
Priyal Mistry, Fatima Barmania, Juanita Mellet, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 275
Analysis of 6.4 million SARS-CoV-2 genomes identifies mutations associated with fitness
Fritz Obermeyer, Martin Jankowiak, Nikolaos Barkas, et al.
Science (2022) Vol. 376, Iss. 6599, pp. 1327-1332
Open Access | Times Cited: 274
Fritz Obermeyer, Martin Jankowiak, Nikolaos Barkas, et al.
Science (2022) Vol. 376, Iss. 6599, pp. 1327-1332
Open Access | Times Cited: 274
Outbreak.info genomic reports: scalable and dynamic surveillance of SARS-CoV-2 variants and mutations
Karthik Gangavarapu, Alaa Abdel Latif, Julia L. Mullen, et al.
Nature Methods (2023) Vol. 20, Iss. 4, pp. 512-522
Open Access | Times Cited: 273
Karthik Gangavarapu, Alaa Abdel Latif, Julia L. Mullen, et al.
Nature Methods (2023) Vol. 20, Iss. 4, pp. 512-522
Open Access | Times Cited: 273